Your session is about to expire
← Back to Search
tapinarof cream, 1% for Atopic Dermatitis
Study Summary
This trial is testing whether a new cream is better than the standard cream for treating atopic dermatitis.
- Atopic Dermatitis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 3 trial • 763 Patients • NCT04053387Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA cleared tapinarof cream, 1% for use?
"There is both anecdotal and clinical evidence supporting the safety of tapinarof cream, 1%, which our team has rated a 3."
How many people are involved in this research project?
"That is correct, the clinical trial is currently recruiting patients. The original posting was on September 23rd, 2021 and there have been subsequent edits made on January 28th, 2022. In total, 400 participants are needed from 72 different locations."
Has tapinarof cream, 1% been studied before in other clinical trials?
"The first study evaluating the efficacy of tapinarof cream, 1% was completed in 2021 at Peking University People's Hospital. As of now, a total of 16 clinical trials have been completed with 5 more currently underway. Many of these studies are being conducted out of Scottsdale, Arizona."
Is this research being conducted in multiple hospitals across North America?
"This study is currently running at 72 sites. The sites are located in Scottsdale, Las Vegas and Spartanburg as well as other cities 72 other locations. To minimize travel requirements, you should select the location nearest to you if you decide to enroll in this trial."
Are we still able to sign patients up for this clinical experiment?
"Yes, this information is accurate. The clinical study in question was originally posted on September 23rd 2021 and updated most recently on January 28th of this year."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger